The Precision Peptide Company Inc. BPC
CNSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -332.78% | -468.74% | -460.38% | -333.94% | -61.19% |
| Total Depreciation and Amortization | -4.31% | 5,400.00% | 3,373.68% | 2,438.46% | 2,800.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4,092.31% | 3,682.75% | 1,558.19% | 941.17% | -72.35% |
| Change in Net Operating Assets | -916.95% | -1,064.64% | -228.93% | -248.45% | -17.32% |
| Cash from Operations | -253.84% | -276.11% | -613.45% | -500.77% | -174.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 299.68% | 261.92% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 244.39% | 216.84% | -- | -- | -- |
| Total Debt Issued | 461.80% | 461.80% | 355.66% | 461.80% | -- |
| Total Debt Repaid | 0.56% | -11.24% | -- | -- | -- |
| Issuance of Common Stock | 219.58% | 15.41% | 70.45% | 131.52% | 325.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -99.82% | -- | -- | -- | 108,700.00% |
| Cash from Financing | 19.67% | 201.27% | 466.16% | 547.45% | 1,039.76% |
| Foreign Exchange rate Adjustments | -1,109.09% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 200.00% |
| Net Change in Cash | -103.77% | 338.43% | 56.65% | 831.99% | 1,036.21% |